Manhattan Eye, Ear and Throat Hospital is a specialty hospital in New York City that was founded in 1869 and is currently located on the Upper East Side of Manhattan at 210 East 64th Street.

During the past decade, Manhattan Eye, Ear & Throat Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Manhattan Eye, Ear & Throat Hospital" #1 sponsor was "Manhattan Eye, Ear & Throat Hospital" with 13 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "Aerie Pharmaceuticals" with 1 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Ardeshir Rastinehad" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Manhattan Eye, Ear & Throat Hospital" #1 collaborator was "Alcon Research" with 10 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Philips Healthcare" with 2 trials as a collaborator, "Bascom Palmer Eye Institute" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Manhattan Eye, Ear & Throat Hospital" are "Chronic Central Serous Chorioretinopathy" (2 trials), "Prostate Cancer" (2 trials), "Prostate Disease" (2 trials), "Recurrent Ovarian Carcinoma" (2 trials) and "Advanced Malignant Solid Neoplasm" (1 trials). Many other conditions were trialed in "Manhattan Eye, Ear & Throat Hospital" in a lesser frequency.

Most popular intervention types in "Manhattan Eye, Ear & Throat Hospital" are "Drug" (20 trials), "Other" (7 trials), "Procedure" (7 trials), "Biological" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (4 trials), "Anecortave Acetate" (3 trials), "Anecortave Acetate Sterile Suspension (15 mg)" (3 trials), "Magnetic Resonance Imaging" (3 trials) and "Nivolumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Manhattan Eye, Ear & Throat Hospital" are 22 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Manhattan Eye, Ear & Throat Hospital". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Manhattan Eye, Ear & Throat Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Manhattan Eye, Ear & Throat Hospital, 2 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".